Literature DB >> 18564394

Discrete Toll-like receptor agonists have differential effects on alloimmunization to transfused red blood cells.

Jeanne E Hendrickson1, John D Roback, Christopher D Hillyer, Kirk A Easley, James C Zimring.   

Abstract

BACKGROUND: Factors influencing alloimmunization to transfused red blood cells (RBCs) are not well understood. Utilizing a murine model, we have recently reported that RBC alloimmunization is enhanced by recipient treatment with viral-like polyinosinic polycytidylic acid (poly(I:C)). To determine whether a different subtype of inflammation also enhances RBC alloimmunization, we investigated the effects of the bacterial endotoxin lipopolysaccharide (LPS) on alloimmunization. STUDY DESIGN AND METHODS: Mice were treated with poly(I:C) or LPS; in select experiments, the precursor frequency of naïve antigen-specific CD4+ T cells was increased using T cells from T-cell receptor transgenic mice. Recipients were transfused with leukoreduced RBCs expressing the membrane-bound hen egg lysozyme (mHEL) antigen, and alloimmunization was measured by anti-HEL immunoglobulin G responses using enzyme-linked immunosorbent assay and flow cytometric cross-match. Costimulatory molecule expression was examined on antigen-presenting cells (APCs) by flow cytometry.
RESULTS: Increased expression of costimulatory molecules on APCs was seen after treatment with either poly(I:C) and LPS. In contrast to the enhancement of RBC alloimmunization observed after treatment with poly(I:C), LPS not only failed to enhance but also actively suppressed alloimmunization, even in the presence of increased mHEL-specific CD4+ T cells (p < 0.001 LPS vs. control).
CONCLUSIONS: These data demonstrate that the regulation of RBC alloimmunization by inflammatory stimuli is complex, including enhancement by a viral-like stimulus and suppression by a bacterial-type stimulus. The mechanism(s) are unlikely to involve variation in the costimulatory molecules studied, because only subtle differences on APCs were observed after treatment with poly(I:C) and LPS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18564394     DOI: 10.1111/j.1537-2995.2008.01801.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  19 in total

Review 1.  Use of mouse models to study the mechanisms and consequences of RBC clearance.

Authors:  E A Hod; S A Arinsburg; R O Francis; J E Hendrickson; J C Zimring; S L Spitalnik
Journal:  Vox Sang       Date:  2010-03-21       Impact factor: 2.144

2.  Alloimmunization against RBC or PLT antigens is independent of TRIM21 expression in a murine model.

Authors:  Seema R Patel; Jeanne E Hendrickson; Nicole H Smith; Chantel M Cadwell; Keiko Ozato; Herbert C Morse; Ryusuke Yoshimi; James C Zimring
Journal:  Mol Immunol       Date:  2011-01-26       Impact factor: 4.407

3.  Whole-blood phenotyping to assess alloimmunization status in transfused sickle cell disease patients.

Authors:  Marie Tamagne; Sadaf Pakdaman; Pablo Bartolucci; Anoosha Habibi; Frédéric Galactéros; France Pirenne; Benoît Vingert
Journal:  Blood Adv       Date:  2021-03-09

4.  Transfusion of murine red blood cells expressing the human KEL glycoprotein induces clinically significant alloantibodies.

Authors:  Sean R Stowell; Kathryn R Girard-Pierce; Nicole H Smith; Kate L Henry; C Maridith Arthur; James C Zimring; Jeanne E Hendrickson
Journal:  Transfusion       Date:  2013-04-29       Impact factor: 3.157

5.  Recipient priming to one RBC alloantigen directly enhances subsequent alloimmunization in mice.

Authors:  Seema R Patel; Ashley Bennett; Kathryn Girard-Pierce; Cheryl L Maier; Satheesh Chonat; Connie M Arthur; Patricia E Zerra; Amanda Mener; Sean R Stowell
Journal:  Blood Adv       Date:  2018-01-23

6.  Red blood cell alloimmunization is influenced by the delay between Toll-like receptor agonist injection and transfusion.

Authors:  Rahma Elayeb; Marie Tamagne; Philippe Bierling; France Noizat-Pirenne; Benoît Vingert
Journal:  Haematologica       Date:  2015-10-01       Impact factor: 9.941

7.  B cells require Type 1 interferon to produce alloantibodies to transfused KEL-expressing red blood cells in mice.

Authors:  David R Gibb; Jingchun Liu; Manjula Santhanakrishnan; Prabitha Natarajan; David J Madrid; Seema Patel; Stephanie C Eisenbarth; Christopher A Tormey; Sean R Stowell; Akiko Iwasaki; Jeanne E Hendrickson
Journal:  Transfusion       Date:  2017-08-23       Impact factor: 3.157

8.  Type 1 IFN signaling critically regulates influenza-induced alloimmunization to transfused KEL RBCs in a murine model.

Authors:  Dong Liu; David R Gibb; Vicente Escamilla-Rivera; Jingchun Liu; Manjula Santhanakrishnan; Zhimin Shi; Lan Xu; Stephanie C Eisenbarth; Jeanne E Hendrickson
Journal:  Transfusion       Date:  2019-08-12       Impact factor: 3.157

9.  Storage of murine red blood cells enhances alloantibody responses to an erythroid-specific model antigen.

Authors:  Jeanne E Hendrickson; Eldad A Hod; Steven L Spitalnik; Christopher D Hillyer; James C Zimring
Journal:  Transfusion       Date:  2009-11-09       Impact factor: 3.157

10.  Regulation of primary alloantibody response through antecedent exposure to a microbial T-cell epitope.

Authors:  Krystalyn E Hudson; Eugene Lin; Jeanne E Hendrickson; Aron E Lukacher; James C Zimring
Journal:  Blood       Date:  2010-01-19       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.